{"id": "267244", "url": "https://fevir.net/resources/Evidence/267244", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/comparative-evidence"], "versionId": "9", "lastUpdated": "2025-12-11T20:35:21.032Z"}, "name": "NCT03421379_primaryOutcomeMeasure_0_OutcomeAnalysis_0_BetweenGroupAnalysis_OG000_OG001", "title": "Percentage of Participants Achieving Treatment Success During Controlled Insulin-Induced Hypoglycemia at Pre-dose up to 30 minutes post each glucagon administration Statistical Analysis for Glucagon Nasal Powder vs Glucagon Hydrochloride Solution in NCT03421379", "author": [{"name": "Computable Publishing\u00ae: ClinicalTrials.gov-to-FEvIR Converter"}], "citeAs": "Percentage of Participants Achieving Treatment Success During Controlled Insulin-Induced Hypoglycemia at Pre-dose up to 30 minutes post each glucagon administration Statistical Analysis for Glucagon Nasal Powder vs Glucagon Hydrochloride Solution in NCT03421379 [Database Entry: FHIR Evidence Resource]. Contributors: Computable Publishing\u00ae: ClinicalTrials.gov-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 267244. Revised 2025-12-11. Available at: https://fevir.net/resources/Evidence/267244. Computable resource at: https://fevir.net/resources/Evidence/267244#json.", "status": "active", "contact": [{"telecom": [{"value": "support@computablepublishing.com", "system": "email"}]}], "copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/", "publisher": "Computable Publishing LLC", "statistic": [{"note": [{"text": "Outcome Analysis NonInferiority Type: Non-Inferiority"}, {"text": "Outcome Analysis NonInferiority Comment: The pre-defined non-inferiority margin is (10%)"}], "quantity": {"unit": "percentage of participants", "value": 0}, "statisticType": {"text": "Treatment Difference Wald's Method"}, "attributeEstimate": [{"note": [{"text": "CI Number of Sides: 2-Sided"}], "type": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/attribute-estimate-type", "code": "C53324", "display": "Confidence interval"}]}, "level": 0.95, "range": {"low": {"unit": "percentage of participants", "value": -1.47}, "high": {"unit": "percentage of participants", "value": 1.47}}}]}], "identifier": [{"type": {"text": "FEvIR Object Identifier", "coding": [{"code": "ACSN", "system": "http://terminology.hl7.org/CodeSystem/v2-0203", "display": "Accession ID"}]}, "value": "267244", "system": "https://fevir.net/FOI", "assigner": {"display": "Computable Publishing LLC"}}, {"type": {"text": "FEvIR Linking Identifier"}, "value": "NCT03421379-primaryOutcomeMeasure-0-OutcomeAnalysis-0-BetweenGroupAnalysis-OG000-OG001", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}], "resourceType": "Evidence", "variableDefinition": [{"note": [{"text": "All randomized participant who completed both treatment visits and had evaluable treatment success data."}], "intended": {"type": "Group", "reference": "Group/267225", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "NCT03421379 Eligibility Criteria", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}, "variableRole": "population"}, {"observed": {"display": "Group Assignment: A single dose of 3 mg glucagon nasal powder was administered intranasally vs. A single dose of 1 mg glucagon hydrochloride solution was administered IM"}, "description": "Group Assignment: Glucagon Nasal Powder vs. Glucagon Hydrochloride Solution", "variableRole": "exposure", "comparatorCategory": "Glucagon Hydrochloride Solution"}, {"observed": {"type": "EvidenceVariable", "display": "Percentage of Participants Achieving Treatment Success During Controlled Insulin-Induced Hypoglycemia at Pre-dose up to 30 minutes post each glucagon administration (NCT03421379)", "reference": "EvidenceVariable/267226", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "value": "NCT03421379-primaryOutcome-0", "system": "https://fevir.net/FLI", "assigner": {"display": "Computable Publishing LLC"}}}, "variableRole": "outcome"}], "description": "This Evidence Resource is referenced in an example for the EBMonFHIR Implementation Guide."}